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Human SH-SY5Y neuroblastoma cells have been used to investigatemechanisms involved in
CREB phosphorylation after activation of two endogenously expressed Gq/11-protein-coupled
receptors, the M3 muscarinic acetylcholine (mACh) and B2 bradykinin receptors. Stimulation
with eithermethacholine or bradykinin resulted inmaximal increases in CREB phosphoryla-
tion within 1 min, with either a rapid subsequent decrease (bradykinin) to basal levels, or a
sustained response (methacholine). Inhibitor studies were performed to assess the involve-
ment of a number of potential kinases in signalling to CREB phosphorylation. Removal of
extracellular Ca2+, inhibition of Ca2+/calmodulin-dependent protein kinase II and down-
regulation of protein kinase C (PKC) resulted in reduced CREB phosphorylation after both
M3 mACh and B2 bradykinin receptor activation. In contrast, inhibition of MEK1/2 by U0126
resulted in significantly reduced CREB phosphorylation levels after B2 bradykinin, but not M3
mACh receptor activation. In addition, we demonstrate that maintained phosphorylation of
CREB is necessary for CRE-dependent gene transcription as the M3 mACh, but not the B2
bradykinin receptor activates both a recombinant CRE-dependent reporter gene, and the
endogenous c-Fos gene. These data highlight the involvement of multiple, overlapping
signalling pathways linking these endogenous Gq/11-coupledmetabotropic receptors to CREB
andemphasize the importanceof thedurationofsignallingpathwayactivation inconvertinga
CREB phosphorylation event into a significant change in transcriptional activity.
# 2007 Elsevier Inc.
avai lable at www.sc iencedi rec t .com
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Open access under CC BY license.1. Introduction
Adaptive responses in neurons often involve changes in gene
expression, which allow long-term phenotypic changes such
as differentiation of precursor cells, or synaptic strengthening
ofmature neurones. Such changes in gene expression occur in
the CNS via the activity of neuronal transcription factors such
as the cyclic AMP response-element binding-protein (CREB),* Corresponding author. Tel.: +44 116 229 7146; fax: +44 116 252 5045.
E-mail address: jc36@leicester.ac.uk (R.A. John Challiss).
Abbreviations: CREB, cyclic AMP response-element binding-prote
coupled receptor; IBMX, 3-isobutyl-1-methylxanthine; mACh, muscar
phorbol 12,13-dibutyrate; PKA, cyclic AMP-dependent protein kinase;
0006-2952 # 2007 Elsevier Inc.
doi:10.1016/j.bcp.2007.10.015
Open access under CC BY license.nuclear factor of activated T cells (NF-AT) and nuclear factor-k
enhancer binding-protein (NF-kB). CREB activity is induced in
a vast array of cell types [1], in neuronal cells these signalsmay
be in the formof synaptic transmissions, neurotransmitters or
neurotrophic factors. CREB is activated by the phosphoryla-
tion of a specific serine residue (Ser-133) within its kinase-
inducible domain (KID), in response to a variety of extra-
cellular signals [2]. This leads to the activation of so-calledin; ERK, extracellular signal-regulated kinase; GPCR, G-protein-
inic acetylcholine; MAPK, mitogen-activated protein kinase; PDBu,
PKC, protein kinase C; PLC, phospholipase C.
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kinase (PKA; [3]), Ca2+/calmodulin-dependent protein kinases
[4–6] ribosomal S6 kinases [7], extracellular signal-regulated
kinases (ERK; [8,9]), protein kinase B [10] and protein kinase D
[11]. In addition, protein kinase C (PKC) activation has been
linked to CREB phosphorylation in numerous studies, but only
occasionally has a direct phosphorylation been demonstrated
[12]. Thus, it is likely that CREB phosphorylation by PKC often
involves one or more intermediate kinases.
Signalling events leading to phosphorylation of CREB
following synaptic activity have been well characterized
[13–17]. Less well understood however, are the specific
mechanisms leading to CRE-dependent gene transcription
following G-protein-coupled receptor (GPCR) activation.
Another layer of complexity is added if the variety of gene
products expressed as a result of activation of a single
transcription factor such as CREB is taken into account. To
allow this specificity of response, strict regulatory events are
required. One of the ways in which this specificity is
accomplished is through differing Ca2+ signals. Firstly, the
spatial characteristics of increases in intracellular Ca2+ can
differentially activate either cytoplasmic or nuclear effector
molecules. Hardinghamet al. [18] demonstrated that increases
in nuclear Ca2+ concentration result in the activation of CREB
and hence CRE-dependent gene expression. A second signal-
ling pathway that resulted in increases in cytoplasmic Ca2+
concentration led to the activation of serum-response-
element (SRE)-dependent gene expression. In addition, the
site of Ca2+ entry may be important, such that Ca2+ ions
entering at dendritic loci, as opposed to the cell body, may
cause a different complement of proteins to be activated.
The type of Ca2+ signal created can also influence the
response achieved. The release of Ca2+ from intracellular stores
can occur as a peak or peak-and-plateau type response, or an
oscillatory response. Ca2+ oscillations have been shown to
increase the efficiency of gene expression by lowering the
effective Ca2+ threshold for transcription factor activation [19].
The temporal profile of the Ca2+ signal determines the
magnitude of response obtained, so that although short bursts
of Ca2+ elevation are sufficient to initiate gene transcription,
prolonged signalling is required for a maximum response [20].
To investigate the roles of some of these differences in Ca2+
signalling, we have utilized the neuronal SH-SY5Y cell-line
that shares many characteristics with foetal sympathetic
ganglion cells [21]. This cell-line expresses at least two
endogenous Gq/11-coupled GPCRs, the M3 muscarinic acet-
ylcholine (mACh), and B2 bradykinin receptors [22]. Activation
of these two receptors results in downstream signalling
cascades, and activation of kinases capable of phosphorylat-
ing CREB. For this reason, the SH-SY5Y cell-line represents a
suitable cell model to investigate mechanisms involved in
GPCR coupling to CREB within a neuronal context.2. Materials and methods
2.1. Materials
All chemicals and reagents were purchased from Sigma–
Aldrich (Poole, UK) unless otherwise indicated. Antibodiesraised to 133Ser-phosphorylated CREB and total CREB were
purchased fromNewEngland BioLabs (Beverly, USA); antibody
raised against active phospho-ERK (pERK1/2), Glo-lysis buffer
and Steady-Glo reagent were purchased from Promega
(Madsion, USA); Fura-2-AM was purchased from Molecular
Probes (Cambridge, UK); glass coverslips were purchased from
BDH-Merck (Poole, Dorset); thapsigargin, phorbol 12,13-dibu-
tyrate, Ro 31-8220, U0126 and antibody raised against c-Fos
were purchased from Calbiochem (Nottingham, UK); western
blotting equipment and Tris/glycine/sodium dodecyl sulfate
running buffer were from BioRad (Hertfordshire, UK); nitro-
cellulose transfer membrane was from Schliecher & Schuell
(London, UK); acrylamide was from Flowgen (Leicestershire,
UK); enhanced chemiluminescence and hyperfilm were
purchased from Amersham Pharmacia (Little Chalfont, UK);
all tissue culture reagents were purchased from Invitrogen
(Paisley, UK).
2.2. Cell culture
Human SH-SY5Y neuroblastomas were maintained in mini-
mumessentialmediumwith Earl’s salts (without L-glutamate)
supplemented with foetal bovine serum (10%), penicillin
(100 IU mL1), streptomycin (100 mg mL1) and L-glutamine
(2 mM), at 37 8C, 5%CO2. For experiments, cellswere harvested
using trypsin/EDTA and seeded on to multiwell plates in
medium composed as above. All experimental manipulations
with viable cells were performed at 37 8C.
2.3. Preparation of cell lysates
Cell lysates were prepared as described previously [23,24].
Prior to agonist stimulation, monolayers were washed twice
and incubated for 30 min at 37 8C in freshly oxygenated
Krebs-Henseleit buffer (KHB (in mM); 10 HEPES, 118 NaCl, 4.7
KCl, 1.2 MgSO4, 1.2 KH2PO4, 4.2 NaHCO3, 1.3 CaCl2, 11.7
glucose, pH 7.4). Drug additions were made directly to the
KHB at concentrations and time-points indicated in the
figure legends, and after indicated treatments plates were
placed on ice. Cell stimulations were terminated by rapid
removal of the agonist-containing buffer, followed by two
washes with ice-cold phosphate buffered saline (PBS (in
mM); 140 NaCl, 2.68 KCl, 8.1 Na2HPO4, 1.47 KH2PO4, pH 7.4),
and solubilization using relevant lysis procedures (see
below).
For pCREB and c-Fos determination cells were lysed by
addition of 150 mL 1 SDS sample buffer (62.5 mM Tris/HCl,
2% SDS, 10% glycerol, 0.1% bromophenol blue, 50 mM
dithiothreitol (DTT), pH 7.4), immediately scraped off the
plate and transferred to a microfuge tube. Cell lysates were
sonicated for 20 s to shear DNA and reduce sample viscosity,
boiled for 5 min and centrifuged at 20,000  g for 1 min
at 4 8C.
For pERK determination, cells were solubilized in lysis
buffer (20 mM Tris/HCl, 1% Triton-X100, 10% glycerol, 137 mM
NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 1 mM Na3VO4,
1 mM phenylmethylsulfonyl fluoride, 10 mgml1 leupeptin,
10 mgml1 aprotinin, pH 7.4) and centrifuged (33,000  g,
10 min, 4 8C) to remove insoluble material. Aliquots of super-
natant were removed and added to equivalent volumes of 2
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centrifuged (20 000 g, 1 min, 4 8C).
2.4. Western blotting analysis
Samples for western blotting (25 mL) were separated by 10%
SDS-polyacrylamide gel electrophoresis using the BioRad
minigel system. Proteins were electro-transferred to nitro-
cellulose membrane using the BioRad semi-dry blotter
apparatus according to manufacturer’s instructions. Follow-
ing electro-transfer, the membranes were blocked for non-
specific binding at room temperature (20 8C) for 1 h in Tris-
buffered saline (50 mM Tris/HCl, 150 mM NaCl, pH 7.6)
containing 0.1% Tween-20 (TBS-T), supplemented with 5%
non-fat milk. After blocking, membranes were washed in
TBS-T, and incubated overnight at 4 8C with the either
polyclonal pCREB-specific antibody (1:1000 dilution in 5%
milk/TBS-T), the polyclonal anti-active pERK1/2 (1:5000 in 1%
BSA/TBS-T), or the polyclonal anti-c-Fos antibody (1 mg mL1
in 5%milk/TBS-T). Primary antibodieswere detected for 1 h at
room temperature with a secondary antibody (goat anti-
rabbit; 1:1000 dilution in 5% milk/TBS-T) conjugated to
horseradish peroxidase. This was followed by chemilumi-
nescence detection using ECL-plus reagent and exposure to
HyperFilmTM (Amersham Life Science). To ensure equal
protein loading across the gel, membranes were submerged
in stripping buffer (62.5 mM Tris/HCl, 100 mM 2-mercap-
toethanol, 2% (w/v) SDS, pH 6.7), and incubated at 50 8C for
40 min, and re-probed with a polyclonal control CREB anti-
body, or the anti-tubulin antibody, followed bydetectionwith
the same secondary antibody.
2.5. Measurement of Ins(1,4,5)P3 mass
Cells were grown to confluency in 24-well multiwell plates for
the measurement of Ins(1,4,5)P3 mass, which was performed
as described previously [25]. In brief, cells were washed with
KHB and incubated at 37 8C for 30 min. Agonist additions were
made directly to the KHB. Reactions were stopped by the
addition of an equal volume (250 mL) of ice-cold 1 M trichlor-
oacetic acid (TCA), and following neutralization the
Ins(1,4,5)P3 content was determined.
2.6. Single-cell imaging of intracellular Ca2+
Changes in the levels of [Ca2+]i were followed in Fura-2AM
(2 mM, 1 h) loaded cells using a Nikon Diaphot inverted
epifluorecence microscope. Cells were seeded on 25 mm glass
coverslips, and incubated overnight at 37 8C. Prior to imaging,
cells were washed with Krebs-Henseleit buffer and incubated
with 2 mM Fura-2 AM for 1 h, in the dark at room temperature.
After washing, coverslips were maintained in KHB and
mounted on the microscope stage. Drugs were made up in
KHB and perfused over cells for the required time intervals.
Cells were excited at 340 and 380 nm using a Spectramaster II
monochromator (Perkin-Elmer Life Sciences) and sequential
images were captured via a charge-coupled device camera
(Photonic Science) using Merlin2000 data acquisition system
(Perkin-Elmer Life Sciences). Changes in cytosolic Ca2+ were
measured by converting the 340/380 nm fluorescence ratio(after background subtraction) to [Ca2+]i using the method of
Grynkiewicz et al. [26].
2.7. Recombinant pCRE-LUC reporter gene assay
After overnight incubation on 24-well multiwell plates, cells
were co-transfected with 0.5 mg mL1 pCRE-luc reporter using
Lipofectamine. Cells were incubated with Lipofectamine and
DNA (3:1 ratio) for 5 h in growth medium devoid of all
supplements, after which time medium was changed to
complete growth medium. On the third day of growth cells
werewashed, and incubated overnight in serum-freemedium.
On the day of the experiment, cells were treated with agonist
in serum-free medium for times indicated in figure legends,
followed by further incubation in serum-freemedium tomake
6 h incubation in total. Cells were harvested using 150 mL Glo-
lysis buffer for 5 min, after a brief wash with Dulbecco’s PBS.
Fifty microlitres of cell lysates and 50 mL of Steady-Glo reagent
were added to wells of a black, 96-well plate, and incubated at
room temperature for 5 min, after which time luminescence
was quantified.
2.8. Quantification and data analysis
Immunoreactivities were quantified using the Syngene Gen-
eGnome Systemwith Gene Tools software. Data were fitted as
sigmoidal concentration-response curves and statistical dif-
ferences between datasets determined by one-way analysis of
variance (ANOVA) for multiple comparisons, followed by
Bonferroni’s multiple-range test at p < 0.05, using GraphPad
Prism 4 software (GraphPad, San Diego, CA).3. Results
3.1. GPCR-mediated CREB phosphorylation in SH-SY5Y
cells
The ability of M3 mACh and B2 bradykinin receptors to cause
the phosphorylation of CREB was initially assessed by
challenging SH-SY5Y cells with methacholine (MCh; 1 mM)
or bradykinin (300 nM) for 0–30 min. Activation of either
receptor did not affect total CREB protein expression, however
an early, robust (approximately 10–15-fold) increase in CREB
phosphorylation was observed in response to either MCh or
bradykinin. The temporal profile for CREB phosphorylation
differed for the two receptors being studied: MCh caused a
rapid increase in CREB phosphorylation, which was maximal
within 1 min (approximately 12-fold-over-basal) and declined
to a steady-state plateau (approximately 6-fold-over-basal)
after 5 min (Fig. 1A). In contrast, while bradykinin causes a
similar initial increase in CREB phosphorylation (approxi-
mately 14-fold-over-basal at 1 min), a subsequent rapid
decrease was observed such that 5–30 min values were not
significantly greater than basal levels (Fig. 1B). Assessment of
concentration-dependencies for agonist-stimulated CREB
phosphorylation revealed EC50 values of 0.89 mM (pEC50,
6.05  0.06) and 168 nM (pEC50, 6.76  0.08) for MCh and
bradykinin, respectively (Fig. 1C and D). With respect to the
CREB phosphorylation response to MCh stimulation, prior
Fig. 1 – Time-courses and concentration-dependencies for receptor-mediated phosphorylation of the transcription factor
CREB in SH-SY5Y cells. Time-dependent increases in phospho-CREB immunoreactivity after stimulation of cells with either
methacholine (1 mM; A) or bradykinin (300 nM; B). A representative immunoblot for phospho-CREB and total CREB is shown
beneath each graph (Ctr, buffer addition; 10–300, times (in min) of exposure to agonist; Fk, response to addition of 10 mM
forskolin/500 mM IBMX for 10 min). MCh activation resulted in significant (*p < 0.05; **p < 0.01; ***p < 0.001) increases in
phospho-CREB between 1 and 30 min stimulation, while activation by bradykinin resulted in a significant increase in
phospho-CREB only after 1 min of stimulation. Concentration-dependent increases in phospho-CREB immunoreactivity
were assessed at a 5 min time-point for M3 mACh receptor (C) or B2 bradykinin receptor (D) stimulation with the indicated
concentrations of agonist. For each individual experiment, data have been normalized to the increase in phospho-CREB
observed in the presence of a maximal concentration of agonist (100 mMmethacholine and 30 mM bradykinin, respectively).
For each panel, data are shown as meansW S.E.M. for at least 3 independent experiments.
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addition of atropine 5 min afterMChalso caused a rapid return
to baseline within 5 min of antagonist addition (data not
shown).
3.2. Analysis of second messenger signalling in SH-SY5Y
cells
Addition of the MCh (300 mM) resulted in an approximately 3-
fold increase in levels of Ins(1,4,5)P3. Similar to increases in
phospho-CREB, this response demonstrated peak-plateau
type characteristics that were sustained for at least 15 min
(Fig. 2A). Both the peak-and-plateau phases of the response
were shown to be concentration-dependent (data not shown),
with EC50 values of 30 mM (pEC50, 4.52  0.30) and 7.7 mM(pEC50, 5.12  0.23) for peak (15 s) and plateau (5 min) phases,
respectively. Stimulation of cells with bradykinin (10 mM)
resulted in a transient, 2-fold increase in Ins(1,4,5)P3 (Fig. 2A).
Again, this response was concentration-dependent, with an
EC50 of 103 nM (pEC50, 6.98  1.21) (data not shown).
In addition to the classical Ins(1,4,5)P3 pathway, the M3
mACh and B2 bradykinin receptors are also capable of
activating cyclic AMP accumulation. In the case of the M3
mACh receptor this occurs via a pertussis toxin-insensitive
mechanism [27], suggesting the activation of Ca2+-dependent
adenylate cyclases. Here, activation of the two receptors using
MCh (300 mM, 5 min) or bradykinin (10 mM, 5 min) only
resulted in a significant increase in cyclic AMP levels when
cells were pre-treated with the phosphodiesterase inhibitor 3-
isobutyl-1-methylxanthine (IBMX; 500 mM) (data not shown).
Fig. 2 – Time-courses for receptor-mediated increases in Ins(1,4,5)P3 and Ca
2+ mobilization. Time-dependent increases in
Ins(1,4,5)P3 (A) or [Ca
2+]i (B) after stimulation of cells with either MCh (300 mM) or bradykinin (30 mM). In (A), data are shown
as meansW S.E.M. for at least 3 independent experiments; in (B) representative traces are shown.
Fig. 3 – Effects of membrane depolarization on agonist-
induced increases in CREB phosphorylation in SH-SY5Y
cells. The effect of increasing extracellular [K+] (from 4.7 to
44.7 mM) per se, or in combination with MCh (1 mM) or
bradykinin (300 nM) addition on phospho-CREB
immunoreactivity was assessed in confluent SH-SY5Y cell
monolayers. Representative immunoblots for phospho-
CREB and total CREB are shown beneath the histogram
(Ctr, buffer only addition; M, MCh (1 mM); B, bradykinin
(300 nM); K+, +40 mM K+; M/K+ and B/K+, K+-depolarization
in presence of respective agonist). Histogram data are
shown as meansW S.E.M. for at least 3 independent
experiments.
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ling through the M3 mACh and B2 bradykinin receptors have
different temporal profiles. In our hands, addition of MCh
(100 mM, 3 min) resulted in a prolonged Ca2+ signal that was
sustained throughout the duration of receptor activation
(Fig. 2B). When agonist was washed from cells, the [Ca2+]i
returned to basal levels. Challenge of SH-SY5Y cells with
bradykinin (10 mM, 3 min) also resulted in a peak [Ca2+]i,
although basal levels were regained after approximately
2 min, indicating a lack of a sustained [Ca2+]i elevation
(Fig. 2B). MCh elicited an increase in the Ca2þi signal with an
EC50 of 0.8 mM (pEC50, 6.11  0.12), bradykinin elicited a peak
increase in Ca2þi signal with an EC50 of 13 nM (pEC50,
7.90  0.39) (data not shown).
3.3. Effect of membrane depolarization on CREB
phosphorylation in SH-SY5Y cells
The effect of K+-depolarization on CREB phosphorylation per
se, and on receptor-mediated CREB phosphorylation was
assessed in SH-SY5Y cells. Depolarization-induced Ca2+ entry
by addition of 40 mM K+ resulted in an approximately 4-fold
increase in pCREB (Fig. 3). However, the peak M3 mACh or B2
bradykinin receptor-mediated CREB phosphorylation
responses were not significantly affected by concurrent
depolarization (Fig. 3).
3.4. Effect of altering Ca2+ gradients on receptor-mediated
CREB phosphorylation
It has been demonstrated previously that CREB is a Ca2+-
dependent transcription factor inmany cell systems [2,29]. For
this reason, the effect of removing extracellular Ca2+ (Ca2þe ) on
receptor-mediated CREB phosphorylation was assessed
(Fig. 4). Removal of Ca2þe from the perfusion medium and
addition of EGTA (100 mM) resulted in removal of the sustained
phase of the MCh-stimulated [Ca2+]i response (Fig. 4A) and a
marked inhibition of receptor-mediated CREB phosphoryla-
tion (by 61  13% (at 1 min) and 76  13% (at 5 min) compared
to responses in the presence of normal (1.3 mM) Ca2þe ; Fig. 4C)).
Combined Ca2þe removal/EGTA addition plus thapsigargintreatment (to empty Ca2þi stores) resulted in a complete
abolition of the MCh-stimulated [Ca2+]i response, but no
greater inhibition of the receptor-mediated CREB phosphor-
ylation response (data not shown).
Although removal of Ca2þe only slightly altered the
bradykinin-stimulated [Ca2+]i response (Fig. 4B) this manip-
ulation had a marked inhibitory effect on CREB phosphoryla-
tion stimulated by the B2 bradykinin receptor (62  13% (at
1 min) and 74  10% (at 5 min) inhibitions compared to
responses elicited in normal KHB; Fig. 4D)). Again, combined
Fig. 4 – Extracellular Ca2+-dependency of agonist-stimulated CREB phosphorylation in SH-SY5Y cells. Representative [Ca2+]i
traces for responses stimulated by MCh (100 mM; A) and bradykinin (30 mM; B) in Fura-2AM-loaded cells. Experiments were
performed in normal KHB (1.3 mM Ca2þe ) or under conditions where Ca
2þ
e was depleted prior to agonist addition. The effects
of the manipulation of Ca2+ gradients on agonist-stimulated changes in phospho-CREB immunoreactivity were assessed
for MCh (1 mM; 1 or 5 min; C) or bradykinin (300 nM; 1 and 5 min; D). For each panel representative phospho-CREB, total
CREB and g-tubulin blots are shown. Responses were normalized with respect to the response to forskolin (10 mM)/IBMX
(500 mM) addition for 10 min (Fk) in normal KHB (=100%) and are shown as meansW S.E.M. for at least 3 separate
experiments. Statistically significant differences between agonist-stimulated responses under the different Ca2+ conditions
are indicated as *p < 0.05 or ***p < 0.001.
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resulted in complete abolition of the bradykinin-stimulated
[Ca2+]i response, but no greater inhibition of the receptor-
mediated CREB phosphorylation response (data not shown).
Removal of Ca2þi (and/or Ca
2þ
e ) did not significantly affect
forskolin/IBMX-stimulated CREB phosphorylation (Fig. 4C
and D).
3.5. Role of Ca2+/calmodulin-dependent protein kinases
To investigate further the involvement of Ca2+ and the Ca2+-
dependent CaM-kinases in CREBphosphorylation, the effect of
pre-treatment of cells with the CaM-kinase II inhibitor KN93
was assessed with respect to M3 mACh and B2 bradykinin
receptor-stimulated CREB phosphorylation (Fig. 5). In the
presence of KN93 (10 mM, 30 min pre-incubation) both M3
mACh and B2 bradykinin receptor-stimulated increases inCREB phosphorylation were attenuated (40  5 and 51  22%
reductions afterMCh (Fig. 5A); 50  14 and 79  22% reductions
after bradykinin (Fig. 5B), at 1 and 5 min, respectively).
Forskolin/IBMX-stimulated CREB phosphorylation was unaf-
fected in cells treatedwith KN93 (Fig. 5A and B). Similar results
were obtained using KN62 an alternative CaM-kinase II
inhibitor (data not shown).
3.6. Role of protein kinase C
In addition to the CaM-kinases, increases in [Ca2+]i and
diacylglycerol (DAG) will activate a variety of protein kinase
C (PKC) isoenzymes. SH-SY5Y cells have been shown to
express abundantly the conventional PKC isoenzymes a and
bI, and direct activation by the phorbol ester PDBu results in
PKC translocation to the plasma membrane [22,30]. Here, we
have demonstrated that addition of PDBu (1 mM) to SH-SY5Y
Fig. 5 – Effects Ca2+/CaM-kinase inhibition by KN93 on agonist-stimulated CREB phosphorylation in SH-SY5Y cells. KN93
(10 mM) was added to confluent SH-SY5Y cell monolayers 30 min prior to MCh (1 mM, 1 and 5 min; A) or bradykinin (300 nM,
1 and 5 min; B). Cells were also stimulated with forskolin (10 mM)/IBMX (500 mM) for 10 min (Fk). Representative
immunoblots for phospho-CREB, total CREB and g-tubulin are shown beneath each histogram. Data are normalized to the
forskolin/IBMX response (=100%) in the absence of the inhibitor and are shown asmeansW S.E.M. for at least 3 independent
experiments. Statistically significant differences caused by KN93 are indicated as *p < 0.05 and ***p < 0.001.
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isoenzymes results in a marked (approximately 14-fold at
5 min) and sustained increase in phospho-CREB levels
(Fig. 6A). To assess the dependency of MCh- and bradyki-
nin-stimulated CREB phosphorylation on PKC activation, we
chronically treated SH-SY5Y cells with PDBu (1 mM, 20–24 h) to
cause a down-regulation of classic and novel isoenzymes. The
PKC down-regulation protocol resulted in significant reduc-
tions in M3 mACh and B2 bradykinin-stimulated phospho-
CREB (MCh (1 mM), 58  12%; bradykinin (300 nM), 57  10%
reductions compared to control conditions at 1 min; Fig. 6B
and C). It should be noted that, in contrast to a previous report
[31], we observed no change in themorphology of the SH-SY5Y
cells, and M3 mACh receptor expression and coupling to
phosphoinositide turnover was unchanged following PDBu
treatment (data not shown). Nevertheless, as chronic phorbol
ester treatment has been reported to initiate differentiation of
these cells [32], we also used acute PKC inhibition with Ro 31-
8220 (10 mM, 30 min pre-incubation) to confirm that the effects
we observed using PDBu were attributable to PKC inhibition.
This protocol resulted in qualitatively similar inhibitory
effects on agonist-stimulated CREB phosphorylation to those
caused by PKC down-regulation (data not shown).
3.7. Involvement of cyclic AMP-dependent protein kinase
(PKA) and phosphoinositide 3-kinase (PI3-kinase)-dependent
pathways
Stimulation of M3 mACh and B2 bradykinin receptors in SH-
SY5Y cells causes concentration-dependent,modest (2–3-fold)increases in cyclic AMP levels which are either sustained
(pEC50 MCh (at 5 min), 6.54  0.09) or transient (pEC50
bradykinin (at 1 min), 8.12  0.13). However, these responses
required the presence of the phosphodiesterase inhibitor
IBMX (500 mM) and in its absence no significant cyclic AMP
accumulation could be measured for either agonist. Never-
theless, to assess the involvement of a cyclic AMP-dependent
pathway in M3 mACh or B2 bradykinin receptor linkage to
CREB, PKA activitywas inhibited usingH89 (10 mM, 30 min pre-
treatment). H89 had no effect on either MCh- or bradykinin-
stimulated CREB phosphorylation (Fig. 7A), but this inhibitor
did significantly attenuate responses stimulated by forskolin
(in the presence of IBMX).
It has been demonstrated previously that receptor activa-
tion can lead to the phosphorylation of PKB/Akt in SH-SY5Y
cells, and that PKB phosphorylation can be inhibited using the
PI3-kinase inhibitor, wortmannin [33]. Pre-treatment of cells
with wortmannin (100 nM, 30 min) to inhibit the PI3-kinase/
PKB/Akt pathway did not significantly affect CREB phosphor-
ylation stimulated by either M3 mACh or B2 bradykinin
receptor activation (Fig. 7B).
3.8. Involvement of the extracellular signal-regulated
kinase (ERK) pathway
Consistent with previous reports [34,35] activation of M3
mACh receptors caused an approximately 4-fold increase in
phospho-ERK immunoreactivity in SH-SY5Y cells, which are
sustained for at least 30 min (Fig. 8A). In contrast, activation of
the B2 bradykinin receptor resulted in only a transient and
Fig. 6 – Dependency of agonist-stimulated CREB phosphorylation on PKC activity in SH-SY5Y cells. The phorbol ester, PDBu
(1 mM) causes a time-dependent increase in phospho-CREB immunoreactivity (panel A). Effects of chronic phorbol ester
treatment (1 mM PDBu; 24 h treatment) on CREB phosphorylation stimulated by MCh (1 mM; 1 and 5 min; B) or bradykinin
(300 nM; 1 and 5 min; C). Cells were also stimulated with forskolin (10 mM)/IBMX (500 mM) for 10 min (Fk). Representative
immunoblots for phospho-CREB, total CREB and g-tubulin are shown beneath each histogram. Data, normalized to the
forskolin/IBMX response (=100%) in the absence of PDBu treatment, are shown as meansW S.E.M. for at least 3 independent
experiments. Statistically significant changes caused by chronic PDBu treatment are indicated as **p < 0.01.
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has been observed previously in the SK-N-SH cell-line [36],
inhibition of ERK1/2 activation using the MEK inhibitor U0126
(10 mM, 30 min pre-treatment) had no effect on M3 mACh
receptor-stimulated CREB phosphorylation (Fig. 8C). However,
in the presence of U0126 the bradykinin-stimulated increase
in phospho-CREB was significantly attenuated (by 51  5 and
81  5% at 1 and 5 min, respectively) (Fig. 8D).3.9. Additivity of effects of extracellular Ca2+ omission,
PKC and ERK pathway inhibition on receptor-driven CREB
phosphorylation
The effects of combining (i) extracellular Ca2+ depletion (KHB -
Ca2+/+EGTA, see Section 2) and PKC inhibition (by chronic
phorbol ester-induced down-regulation), and (ii) PKC inhibi-
tion and ERK pathway inhibition (using the MEK1/2 inhibitor
Fig. 7 – Dependency of agonist-stimulated CREB phosphorylation on PKA or PI3-kinase activities in SH-SY5Y cells. Effects of
the PKA inhibitor H89 (10 mM; 30 min pre-treatment) or the PI3-kinase inhibitor wortmannin (100 nM; 30 min pre-
treatment) on CREB phosphorylation stimulated by MCh (1 mM; 1 and 5 min) or bradykinin (300 nM; 1 and 5 min). Cells were
also stimulated with forskolin (10 mM)/IBMX (500 mM) for 10 min (Fk). Representative immunoblots for phospho-CREB and
total CREB are shown beneath each histogram. Data, normalized to the forskolin/IBMX response (=100%) in the absence of
respective inhibitor treatment, are shown as means W S.E.M. for at least 3 independent experiments. Statistically
significant changes in the forskolin/IBMX response caused by H89 treatment are indicated as *p < 0.05, **p < 0.01.
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depletion with PKC inhibition markedly inhibited the abilities
of MCh (91  5% inhibited at 1 min) and bradykinin (89  9%
inhibited at 1 min) to stimulate CREB phosphorylation to a
greater extent than either treatment alone (data not shown;
see Figs. 4 and 6). In contrast, combining PKC and ERK pathway
inhibition did not result in any greater inhibition than that
seen for PKC inhibition alone (for bradykinin at 1 min: PKC
inhibition, 57  10%; for U0126, 51  5; combined PKC/ERK
inhibition, 41  15%). This non-additivity would be expected
for the MCh-stimulated phospho-CREB response where no
role for ERK can be discerned (see Fig. 8), however,with respect
to the response to bradykinin, these data suggest that the ERK/
PKC effects may be redundant or lie on a common pathway
leading to CREB phosphorylation.
3.10. Do M3 mACh and B2 bradykinin receptor-mediated
effects lead to transcriptional activation?
In the experiments up to this point, Ser-133 phosphorylation
of CREB has been used as a convenient index of the activation
of CRE-mediated gene transcription. To more directly inves-
tigate this we have utilized a recombinant reporter construct
encoding the pCRE-luciferase gene. SH-SY5Y cells were
transiently transfected with the pCRE-Luc reporter and after
72 h were stimulated with either MCh (100 mM) or bradykinin
(30 mM). Stimulation of cells with MCh resulted in a 6-fold
increase in luciferase activity, while bradykinindid not cause a
significant increase relative to vehicle-stimulated cells
(Fig. 9A). Similar to the CREB phosphorylation assay used in
previous results, forskolin treatment resulted in a significant
increase (4-fold) in luciferase activity only when cells were
pre-treated with IBMX (500 mM). Furthermore, phorbol ester
treatment failed to significantly increase CREB-driven lucifer-
ase activity. For MCh, the increase in reporter activity was
shown to be both time- (Fig. 9B) and concentration-dependent
(pEC50, 5.84  0.63; Fig. 9C).In addition to the recombinant reporter gene, we also
assessed the activation of the endogenous CRE-dependent c-
Fos gene. Cells were stimulated with either MCh (100 mM),
bradykinin (30 mM) or PDBu (1 mM) for 2 h. Stimulation of cells
with either MCh or PDBu caused robust increases (approxi-
mately 4–5-fold) in levels of the c-Fos protein. In contrast, no
increase in c-Fos was observed after bradykinin treatment of
cells (Fig. 9D).
PDBu treatment causes a sustained phosphorylation of
CREB (Fig. 6A) similar to that of MCh that we would expect to
see translated into gene transcription. When assessing
endogenous gene transcription using c-Fos a reporter this
proves to be the case, however use of an endogenous pCRE-
luciferase reporter construct fails to demonstrate PDBu-
mediated gene transcription. The apparent contradictory
results obtained for PDBu activation of endogenous versus
exogenous genes may be due to the different time courses
utilized in these assays. The 6 h incubation necessary for
pCRE-Luc reporter gene transcription gives rise to the
possibility that PDBu is down-regulating PKC at this time,
thus explaining why no pCRE-Luc response is observed.4. Discussion
In neuronal systems CREB has been shown to regulate a wide
variety of key processes including development, synaptic
plasticity, memory and neuronal survival decision-making
[1,2,37,38]. In human SH-SY5Y neuroblastoma cells perhaps
most effort has been made to understand the regulation and
role of CREB in cell differentiation and neurite outgrowth.
Thus, retinoic acid and brain-derived neurotrophic factor
(BDNF) have been shown to increase CREB-dependent tran-
scriptional activation and the pathways linking their cognate
nuclear and tyrosine kinase receptors to CREB activation have
been explored at least to some degree [39,40]. With respect to
GPCRs which classically couple to Gi/o proteins, it has been
Fig. 8 – Dependency of agonist-stimulated CREB phosphorylation on ERK activity in SH-SY5Y cells. Time-courses of ERK1/2
phosphorylation stimulated by MCh (1 mM; A) or bradykinin (300 nM; B). Representative immunoblots for phospho-ERK1/2
and total ERK1/2 are shown beneath each histogram. Statistically significant increases in ERK1/2 phosphorylation are
indicated as *p < 0.05, **p < 0.01. The effects of the MEK1/2 inhibitor U0126 (10 mM, 30 min pre-treatment) on MCh (1 mM; at 1
and 5 min; C) or bradykinin (300 nM; at 1 and 5 min; D) stimulated increases in phospho-CREB immunoreactivity.
Representative immunoblots for phospho-CREB, total CREB and phospho-ERK1/2 are shown beneath each histogram. Data,
normalized to the forskolin/IBMX response (=100%) in the absence of inhibitor, are shown as meansW S.E.M. for at least 3
independent experiments. Statistically significant effects of U0126 on CREB phosphorylation are indicated as *p < 0.05,
***p < 0.001.
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calmodulin leading to CREB phosphorylation [41], whereas
nociceptin/orphanin FQ, an endogenous ligand for opioid
receptor-like (NOP) receptor, causes an increase in CREB
phosphorylation through a Ca2+/cAMP pathway in SH-SY5Y
cells [42]. In the present study we demonstrate that the Gq/11-
coupled GPCRs, M3 mACh and B2 bradykinin, can stimulate
CREB phosphorylation, and show that (similar to the increases
in Ins(1,4,5)P3 and [Ca
2+]i stimulated by the M3 mACh and B2bradykinin receptors [22,28]) the temporal profile of CREB
phosphorylation is dependent on the initiating receptor. Thus,
while the initial amplitude of the CREB phosphorylation
response mediated by each receptor is similar, the B2
bradykinin receptor causes a transient Ins(1,4,5)P3/Ca
2+/CREB
response, whereas the M3 mACh receptor causes much more
sustained peak-and-plateau type responses. Like other signal-
ling modules involved in cell fate decision-making (e.g. ERK
[43,44]) the duration as well as the amplitude of CREB
Fig. 9 – Agonist-stimulated effects on pCRE-luciferase reporter gene activity and c-Fos in SH-SY5Y cells. Sub-confluent SH-
SY5Y cells were transfected with the pCRE-luciferase reporter construct as described in Materials and methods. Cells were
treated with MCh (100 mM), bradykinin (30 mM), PDBu (1 mM) or forskolin (10 mM)/IBMX (500 mM) for 1 h, followed by further
5 h incubation in serum-free medium (A). Time-dependency of increases in CREB-dependent luciferase activity after
stimulation of cells with MCh (100 mM) for the times indicated (B). Concentration-dependency of CREB-dependent luciferase
activity after 1 h stimulation with MCh at concentrations indicated (C). In addition, cells were stimulated with MCh
(100 mM), bradykinin (30 mM) or PDBu (1 mM) for 2 h prior to lysis and c-Fos determination (D; see Section 2). A representative
immunoblot showing c-Fos immunoreactivity is shown below the histogram. Data are normalized to the luciferase activity
or c-Fos immunoreactivity detected after assay buffer addition alone, and are presented as meansW S.E.M. for 3
independent experiments each performed in duplicate.
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tional properties of CREB. Thus, accruing data highlight the
ability of neurones to decode information contained in
amplitude, frequency, duration and locus differences in
Ca2+ influx/mobilization [18–20,45], allowing CREB activity to
be tightly regulated with respect to stimulus-specificity. Here
we show that the sustained increase in phospho-CREB
mediated by the M3 mACh receptor is capable of increasing
CREB-dependent reporter gene transcription and c-Fos
expression, whereas the transient signal generated by B2
bradykinin receptor activation, despite being of equivalent
initial amplitude, is not sufficient to mediate these effects.
A number of protein kinases have the ability to phosphor-
ylate CREB within its KID [3–12], therefore, we utilized a range
of kinase-selective inhibitors, and other cell manipulations, to
determine which are involved in M3 mACh and B2 bradykinin
receptor signalling to CREB. By manipulating trans-plasma-
lemmal Ca2+ gradients in the SH-SY5Y cells, we were able to
demonstrate that Ca2+ influx/mobilization is required for M3mACh and B2 bradykinin receptor-mediated CREB phosphor-
ylation. In addition, inhibition of the activity of the CaM-
kinases resulted in approximately 50% inhibition of CREB
phosphorylation mediated by either receptor. This suggests
that one of themechanisms bywhichCa2+ signals lead to CREB
phosphorylation is via the activation of the CaM-kinase family
of proteins, which are known to phosphorylate CREB in
neurones [4,46,47].
As well as the CaM-kinases, there are other potential
effectors of Ca2+ signalling in the cells, including the Ca2+-
dependent PKCa and bI isoenzymes that are expressed in SH-
SY5Y cells [30]. Our data, using chronic phorbol ester exposure
to down-regulate conventional and novel PKC isoenzymes, or
pharmacological PKC inhibition, demonstrate a PKC require-
ment for normal CREB phosphorylation responses to both
MCh and bradykinin. These data add to the growing body of
evidence supporting a role for PKC as an important effector of
CREB phosphorylation [48–50], however, it has yet to be
elucidated whether PKC itself leads to the phosphorylation of
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kinase. To address whether the inhibitory effects of extra-
cellular Ca2+ depletion on agonist-stimulated CREB phosphor-
ylation are (partially) mediated via Ca2+-dependent PKC
isoenzymes, the additivity of extracellular Ca2+ depletion
and PKC inhibition were assessed.We observed a significantly
greater inhibitory effect of combining these manipulations
suggesting that Ca2+-independent (novel) as well as Ca2+-
dependent (conventional) PKC isoenzymesmay be involved in
MCh- and bradykinin-mediated CREB activation.
CREB can also be phosphorylated by the ERK-regulated
kinase, p90 ribosomal S6 kinase [7,8,51]. Herewehavemade an
unexpected observation regarding the ERK/RSK-dependency
of agonist-mediated CREB phosphorylation. Thus, while
stimulation of the M3 mACh receptor causes a robust
activation of ERK in SH-SY5Y cells, inhibition of this pathway
(using the MEK1/2 inhibitor U0126) had no effect on the ability
of MCh to cause CREB phosphorylation. However, in contrast,
stimulation of the B2 bradykinin receptor caused only a
modest and transient activation of ERK, but in this case U0126
significantly inhibited bradykinin-stimulated CREB phosphor-
ylation (see Fig. 8). In addition, we have shown that while the
inhibition of either ERK or PKC (through chronic phorbol ester
treatment) activities each inhibit bradykinin-stimulated CREB
phosphorylation by 50%, combined ERK/PKC inhibition had
no greater effect than inhibiting either pathway alone. These
data suggest that PKC and ERKmay lie on a commonupstream
pathway linking B2 bradykinin receptor activation to CREB
phosphorylation. PKC signalling to ERK has been reported in
the literature [52,53]. Further work examining the profiles of
PKC isoenzymic activation by MCh and bradykinin will be
needed to establish why both M3 mACh and B2 bradykinin
receptors exert PKC-dependent regulations of CREB, yet only
one pathway proceeds via a partially ERK-dependentmechan-
ism.
Previous work has provided strong evidence for a multi-
plicity of protein kinase input to CREB regulation with the
relative contributions of the different kinases varying
through the time-course of the CREB response [47,48,54].
Although in the present study we have implicated a number
of kinases that act downstream of M3 mACh and B2
bradykinin receptors to regulate CREB, we have provided
no evidence for their sequential recruitment to shape the
CREB phosphorylation response. Indeed, our data suggest
that CaM-kinase, PKC and/or ERK-dependent pathways are
all important in initiating the response and other mechan-
isms (e.g. receptor desensitization) are likely to account for
differences in the time-courses of CREB phosphorylation and
transcriptional activation observed for the M3 mACh and B2
bradykinin receptors.
With respect to the connexion between CREB phosphor-
ylation and activation, phosphorylation of CREB at Ser-133 is
commonly assumed to be predictive of the activation of
CRE-dependent transcription, however, several other post-
transcriptional modifications of CREB may occur to influ-
ence the transcriptional activation state of CREB [2,55,56].
Using both an exogenous recombinant reporter construct
and endogenous gene product we have demonstrated that
M3 mACh receptor activation results in an increase in gene
transcription. In contrast, the more transient increase inCREB phosphorylation caused by B2 bradykinin receptor
activation did not translate into significant increases in
either gene product. These data strongly suggest that
sustained increases in CREB phosphorylation are essential
for transcriptional activation in SH-SY5Y cells. It has been
demonstrated previously that a sustained increase in
intracellular Ca2+ is required for the initiation of gene
transcription via CREB in both striatal neurons in response
to metabotropic glutamate receptor activation [57] and
cortical oligodendrocyte progenitor cells [48]. This might
explain the differences in transcriptional ability for the two
receptors studied here. Activation of the M3 mACh receptor
results in the prolonged Ca2+ signal required to initiate
transcription, whereas the B2 bradykinin receptor can only
elicit a transient Ca2+ signal and associated CREB phosphor-
ylation that may be insufficient to facilitate CRE-dependent
transcriptional activity.
Finally, in neurones it is likely that metabotropic and
ionotropic inputswill integrate to determine CREB phosphor-
ylation and transcriptional activity [15–17,29,56]. While
metabotropic and ionotropic inputs may activate CREB via
parallel, independent pathways, it is more likely that
modulatory cross-talk will occur. Thus, our group has
demonstrated ionotropic effects on GPCR signalling in
neurones [58] and provided new evidence that such interac-
tions may be more complex than first thought by demon-
strating that M3 mACh and B2 bradykinin receptor signalling
can be differentially regulated by changes in membrane
potential in SH-SY5Y cells [59]. However, here have shown
that while K+-depolarization can cause a modest increase in
CREB phosphorylation (Fig. 3), concurrent addition of MCh or
bradykinin in the presence of increased extracellular K+ did
not alter the CREB phosphorylation response to the GPCR
agonist alone.
In conclusion, we have demonstrated that activation of
both the M3 mACh and B2 bradykinin receptors lead to the
phosphorylation of the transcription factor CREB via a
primarily Ca2+-dependent mechanism in SH-SY5Y neuro-
blastoma cells. While both GPCRs appear to utilize PKC and
Ca2+/CaM-kinase-dependent pathways, only the B2 brady-
kinin receptor additionally utilized an ERK1/2-dependent
pathway. In contrast to the robust activation of both
endogenous and exogenous indicators of transcriptional
activation by the M3 mACh receptor agonist, the transient
activation of Ca2+, PKC and ERK1/2 mediated by the B2
bradykinin receptor was an insufficient stimulus to bring
about CRE-dependent gene transcription. These data
demonstrate that while two different receptors may activate
the transcription factor CREB via similar, overlapping
pathways, translation of this signal into long-term pheno-
typic changes requires a particular kinetic activation profile.
Furthermore, it will now be crucial to evaluate the
interaction of neuronal-activity and Gq/11-coupled GPCR-
dependent CREB activation and ultimately gene expression
in synaptically active primary neurones. The balance
between protein kinase and protein phosphatase activity
may depend not only on the intrinsic regulation of the
GPCRs, but also the influence of synaptic activity on the
localization of these enzymes and their possible scaffolding
proteins.
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